Submission Details
| 510(k) Number | K143690 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 24, 2014 |
| Decision Date | April 01, 2016 |
| Days to Decision | 464 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K143690 is an FDA 510(k) clearance for the Ekso? (version 1.1) and Ekso GT? (version 1.2), a Powered Exoskeleton (Class II — Special Controls, product code PHL), submitted by Ekso Bionics, Inc. (Richmond, US). The FDA issued a Cleared decision on April 1, 2016, 464 days after receiving the submission on December 24, 2014. This device falls under the Neurology review panel. Regulated under 21 CFR 890.3480.
| 510(k) Number | K143690 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 24, 2014 |
| Decision Date | April 01, 2016 |
| Days to Decision | 464 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | PHL — Powered Exoskeleton |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 890.3480 |
| Definition | A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes. |